FIELD: biology, medicine.
SUBSTANCE: invention relates to media used for reprogramming human and animal stem cells. Medium for the biochemical reprogramming human and animal stem cells containing the medium DI-MEM, fetal calve serum, insulin, 5-azacytidine, L-glutamine comprises additionally the medium F-12, dimethylsulfoxide, dexamethasone, hydrocortisone, N6-2'-dibutyryl-3',5'-cyclic adenosine monophosphate and ethanolamide in the required ratio of components. Invention provides enhancing the effectiveness in reprogramming stem cells in direction of cardiomyogenesis.
EFFECT: improved and valuable properties of medium.
2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDIUM FOR CRYOPRESERVING HUMAN AND ANIMAL CELLS | 2002 |
|
RU2237712C2 |
| CELL CULTURE COMPRISING PRECURSOR CELLS OF OSTEOGENESIS, IMPLANT BASED ON THEREOF AND ITS APPLYING FOR RECOVERY BONE INTEGRITY | 2003 |
|
RU2240135C1 |
| TREATMENT WITH APPLICATION OF PRE-PROGRAMMED MATURE AND DIFFERENTIATED CELLS | 2009 |
|
RU2635317C2 |
| COMPOSITION OF A SERUM-FREE NUTRIENT MEDIUM FOR CULTURING PORCINE MESENCHYMAL STEM CELLS | 2022 |
|
RU2795065C1 |
| BIOTRANSPLANT CONTAINING NUCLEUS-CONTAINING BONE MARROW CELLS INCLUDING PREDIFFERENTIATED IN ENDOTHELIAL AND CARDIOMYOCYTIC DIRECTION, METHOD FOR PRODUCING IT AND METHOD FOR TREATING CARDIAC INSUFFICIENCY CASES | 2006 |
|
RU2314816C2 |
| CELL PRODUCT OF INSULIN-PRODUCING MAMMALIAN CELLS AND USE THEREOF FOR DIABETES MELLITUS THERAPY | 2017 |
|
RU2663118C1 |
| BIOTRANSPLANT, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS (VARIANTS) | 2004 |
|
RU2272638C1 |
| METHODS AND FORMULATIONS FOR CELLS TRANSFECTION | 2012 |
|
RU2624139C2 |
| METHODS AND PREPARATIONS FOR TRANSFECTION OF CELLS | 2012 |
|
RU2691027C2 |
| MEDIUM FOR CULTIVATING BONE MARROW CELLS INTENDED FOR CELLULAR THERAPY | 2020 |
|
RU2756926C1 |
